Champions Oncology, Inc.
CSBR
$5.96
$0.111.88%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -226.97% | 161.24% | 76.24% | -140.82% | 517.45% |
| Total Depreciation and Amortization | -4.48% | -0.28% | -9.14% | -1.01% | -0.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.90% | 34.86% | -17.70% | 13.23% | 446.81% |
| Change in Net Operating Assets | 26.59% | -1,610.05% | -97.42% | 257.15% | -226.93% |
| Cash from Operations | 22.82% | -389.17% | -91.26% | 1,301.63% | 273.14% |
| Capital Expenditure | 84.71% | -426.09% | 81.82% | -502.38% | 55.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 94.21% | -426.09% | 81.82% | -502.38% | 55.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -2.63% | 0.00% | 0.00% | -2.70% |
| Issuance of Common Stock | -98.55% | 762.50% | 300.00% | -84.21% | -86.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -121.43% | 1,300.00% | 56.25% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.22% | -435.00% | -91.80% | 1,369.42% | 424.64% |